Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Integrative Systems

Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug Consumption

Joseph R. Trinko, Benjamin B. Land, Wojciech B. Solecki, Robert J. Wickham, Luis A. Tellez, Jaime Maldonado-Aviles, Ivan E. de Araujo, Nii A. Addy and Ralph J. DiLeone
eNeuro 6 May 2016, 3 (3) ENEURO.0122-15.2016; https://doi.org/10.1523/ENEURO.0122-15.2016
Joseph R. Trinko
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph R. Trinko
Benjamin B. Land
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wojciech B. Solecki
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wojciech B. Solecki
Robert J. Wickham
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis A. Tellez
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
2The John B. Pierce Laboratory, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis A. Tellez
Jaime Maldonado-Aviles
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan E. de Araujo
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
2The John B. Pierce Laboratory, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nii A. Addy
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph J. DiLeone
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Vitamin D3 levels modulate food intake (FI) and body weight (BW). A, HF and HF-D mice exhibited no difference in net body weight between groups over the first 50 d of diet exposure, but a significant increase for the HF-D mice was observed for days 50-100 (n = 10, 10). B, Binned change in body weight for HF and HF-D groups from day 50 to day 101 (n = 10, 10). C, HF and HF-D mice maintained significant differences in body weight throughout the transition from group-housed to single-housed environment from day 101 to day 116 (n = 5, 5). D, Cumulative food intake for HF and HF-D groups from day 101 to day 116 (n = 5, 5). E, Plasma levels of 25(OH)D3 from the HF and HF-D mice on day 165 of their diets (n = 5, 5) used in C and D. F, G, A separate cohort of HF and HF-D mice (n = 5, 5) was killed on day 50 of their diets (F), and serum analysis of 25(OH)D3 levels revealed a significant reduction, despite no differences in body weight (G). H, These mice exhibited a small yet significant reduction in serum calcium levels (n = 5,5). I, Single-housed mice chronically exposed to Ch or Ch-D diets had no significant difference in body weight between groups over days 0-50 or 50-101 (n = 5,5). J, These mice did, however, exhibit increased food intake over both time periods (n = 5, 5). K, At the end of this experiment on day 127, the Ch-D mice were found to have reduced plasma levels of 25(OH)D3. L, A separate cohort of group-housed Ch and Ch-D mice (n = 5, 5) was killed on day 50, and were found to have significantly reduced serum 25(OH)D3 levels. M, These mice displayed no differences in body weight (n = 5, 5). N, Additionally, no differences in serum calcium levels were detected (n = 5, 5).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    A, After 26 d of chronic HF exposure, naive mice were treated with vehicle, calcitriol, or leptin, and displayed reduced net body weight in response only to calcitriol for the first day after single acute treatment (n = 8, 8, 8). B, Calcitriol treatment also reduced food intake for the first day after treatment in these mice (n = 8, 8, 8). C, An additional long-term HF exposure cohort was generated to assess the effects of acute calcitriol treatment on serum calcium levels. After 32 d of the HF diet, mice were treated in the short term and killed 24 h later. No changes in serum calcium levels were observed (n = 8, 8). D, CPA was performed on a separate cohort of naive mice to assess potential aversive effects of calcitriol that could contribute to altered feeding behavior. E, After 4 d of alternating conditioning treatments to specific chambers, there was no difference between groups in the change in the amount of time spent in the paired chamber, yet a significant reduction in net body weight was observed (n = 8, 8). All error bars indicate the SEM.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    VDR is expressed in dopamine-producing, as well as in dopamine-receiving, neurons. A, Colocalization of TH (green) with VDR (purple) in subregions of the midbrain including the VTA and SN. White scale bars indicate a distance of 40 µm. B–E, Colocalization of Cre recombinase (green) with VDR (purple) using the D1R-Cre and D2R-Cre transgenic mouse lines in the nucleus accumbens (Acb; B, C), as well as in the dorsal striatum (Str; D, E).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Calcitriol treatment modulates gene expression differentially throughout dopamine circuitry. A–D, Mouse brain atlas diagrams (Paxinos and Franklin, 2004) showing typical dissections for qPCR analysis (red areas). E–H, Naive mice treated acutely with vehicle (−) or calcitriol (+; n = 5, 5) 6-7 h prior to being killed revealed differential effects of calcitriol in the midbrain, accumbens, and medial and lateral striatum (Str), as assessed by qPCR. All error bars indicate the SEM.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Calcitriol pretreatment enhanced dopamine release in mice and rats in response to amphetamine or dopamine transporter inhibition. All animals received acute pretreatment with calcitriol or vehicle 6-7 h prior to subsequent treatments. A, Microdialysis measuring tonic dopamine release in naive mice (n = 6, 6) revealed the effects of calcitriol on amphetamine-induced dopamine release (red arrow, amphetamine treatment). B, C, FSCV experiments in rats revealed the effects of calcitriol on evoked dopamine release upon treatment with amphetamine (calcitriol, n = 5; vehicle, n = 4) or dopamine transporter inhibition (GBR-12909 dihydrochloride; calcitriol, n = 4; vehicle n = 7). D, E, Representative traces for FSCV experiments. All error bars indicate the SEM.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Vitamin D3 levels alter amphetamine-related behaviors in mice. A, Binned locomotor activity of HF and HF-D mice during habituation, saline injection (black arrow), and acute amphetamine treatment (red arrow). B, HF and HF-D cumulative activity for 20 min after amphetamine administration (n = 5, 5). C, D, Binned locomotor activity of Ch and Ch-D mice during habituation, saline injection (black arrow), and acute amphetamine treatment (red arrow; C), and Ch and Ch-D cumulative activity for 2 h after amphetamine (n = 4, 4; D). E, Binned locomotor activity in naïve mice pretreated with vehicle or calcitriol (n = 8, 8) 6-7 h prior to acute amphetamine treatment (red arrow). F, Cumulative activity of the pretreated mice over 2 h after amphetamine administration.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    A, Oral amphetamine licks for HF and HF-D groups shown in 2 h bins across the 18 h test period (n = 5, 5). B, HF and HF-D group amphetamine preferences shown in 2 h bins across the 18 h test period. C, HF and HF-D amphetamine preference scores grouped for 0-8 and 8-18 h. D, E, Cumulative amphetamine licks for the HF and HF-D mice over the 18 h test period, as well as the total number of licks (amphetamine plus water). F, Oral amphetamine licks for naive mice after single acute calcitriol or vehicle treatment (6-7 h prior to testing) shown in 2 h bins across the 18 h test period (n = 12, 12). G, Amphetamine preference for the calcitriol- and vehicle-treated mice shown in 2 h bins across the 18 h test period. H, Calcitriol and vehicle amphetamine preference scores grouped for 0-8 and 8-18 h. I, J, Cumulative amphetamine licks over the 18 h test period, as well as the total number of licks (amphetamine plus water). All error bars indicate the SEM.

Tables

  • Figures
    • View popup
    Table 1:

    Caloric breakdown of the different diets used for these experiments, as well as dietary vitamin D3 modifications

    DietFat
    (% kcal)
    Protein
    (% kcal)
    Carbohydrate
    (% kcal)
    Combined
    (kcal/g)
    Dietary D3
    (cholecalciferol) (IU/g)
    HF3515504.31.10
    HF-D3515504.3Range: 0.092-0.12
    Ch1426603.22.40
    Ch-D1426603.20.16
    • The range shown for the HF-D diet represents the values observed over multiple batches.

    • View popup
    Table 2:

    Animal usage breakdown by cohort, experiment, species, diets, and days on the respective diets

    CohortExperimentSpeciesDietsDiet length (d)
    1Chronic deficiency, body weight, FIMouse, n = 10,10HF, HF-D116
    (1)Chronic deficiency, plasmaMouse, n = 5, 5HF, HF-D165
    2Chronic deficiency, body Weight, FIMouse, n = 5, 5Ch, Ch-D127
    3Chronic deficiency, body weight, serumMouse, n = 5, 5HF, HF-D50
    4Chronic deficiency, body weight, serumMouse, n = 5, 5Ch, Ch-D50
    5DIO, acute calcitriol, leptin, body weight, FIMouse, n = 8, 8HF30
    6Acute calcitriol, CPAMouse, n = 8, 8Std Chow∼63
    7qPCR analysisMouse, n = 5, 5Std Chow∼63
    8MicrodialysisMouse, n = 6, 6Std Chow∼63
    9FSCVRat, n = 9, 11Std Chown/a
    10Chronic deficiency, amph locomotorMouse, n = 5, 5HF, HF-D166
    (10)Chronic deficiency, amph lickingMouse, n = 5, 5HF, HF-D200
    11Chronic deficiency, amph locomotorMouse, n = 4, 4Ch, Ch-D163
    12Acute calcitriol, amph locomotorMouse, n = 8, 8Std Chow∼63
    13Acute calcitriol, amph lickingMouse, n = 12, 12Std Chow∼63
    • amph, Amphetamine; FI, food intake; Std, standard.

    • View popup
    Table 3:

    Primers using SybrGreen

    GenePrimer
    Drd1Forward5'-GAGCGTGGTCTCCCAGAT-3'
    Drd1Reverse5'-TCACTTTTCGGGGATGCT-3'
    Slc6a3Forward5'-CTGGTGCTGGTCATTGTTCT-'
    Slc6a3Reverse5'-AGCAGGGCTGTGAGGACTAC-3'
    Oprm1Forward5'-CCATCATGGCCCTCTATTCT-3'
    Oprm1Reverse5'-TGTTGGTGGCAGTCTTCATT-3'
    TbpForward5'-AAAGGGAGAATCATGGACCAGAACAA-3'
    TbpReverse5'-TGGACTAAAGATGGGAATTCCAGGAG-3'
Back to top

In this issue

eneuro: 3 (3)
eNeuro
Vol. 3, Issue 3
May/June 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug Consumption
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug Consumption
Joseph R. Trinko, Benjamin B. Land, Wojciech B. Solecki, Robert J. Wickham, Luis A. Tellez, Jaime Maldonado-Aviles, Ivan E. de Araujo, Nii A. Addy, Ralph J. DiLeone
eNeuro 6 May 2016, 3 (3) ENEURO.0122-15.2016; DOI: 10.1523/ENEURO.0122-15.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug Consumption
Joseph R. Trinko, Benjamin B. Land, Wojciech B. Solecki, Robert J. Wickham, Luis A. Tellez, Jaime Maldonado-Aviles, Ivan E. de Araujo, Nii A. Addy, Ralph J. DiLeone
eNeuro 6 May 2016, 3 (3) ENEURO.0122-15.2016; DOI: 10.1523/ENEURO.0122-15.2016
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • dopamine
  • drug addiction
  • feeding
  • obesity
  • vitamin D

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
  • Hsc70 Ameliorates the Vesicle Recycling Defects Caused by Excess α-Synuclein at Synapses
Show more New Research

Integrative Systems

  • Functional connectome correlates of laterality preferences: Insights into Hand, Foot, and Eye Dominance Across the Lifespan
  • Characteristics of Spontaneous Anterior–Posterior Oscillation-Frequency Convergences in the Alpha Band
  • Alpha-Frequency Stimulation Enhances Synchronization of Alpha Oscillations with Default Mode Network Connectivity
Show more Integrative Systems

Subjects

  • Integrative Systems
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.